After careful consideration, Abbott will discontinue Azmacort Inhalation Aerosol effective December 31, 2009. Abbott made this decision based on an international environmental protection agreement known as the Montreal Protocol, which calls for the elimination from the market of certain CFC (chlorofluorocarbon) containing medical products, such as Azmacort.

Patients should talk to their healthcare practitioner about alternative treatments.

If you have any questions, you may contact the Abbott Global Medical Services Department at: 1-800-633-9110.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088 (1-800-332-1088).
If you cannot afford your medication, contact www.pparx.org or call the toll-free phone number
(1-888-4PPA-NOW) (1-888-477-2669) for assistance.

 

300-278303